Stay updated on PEMSYS: Pembrolizumab Modulation Clinical Trial

Sign up to get notified when there's something new on the PEMSYS: Pembrolizumab Modulation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PEMSYS: Pembrolizumab Modulation Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision v3.3.2 has been added and v3.2.0 has been removed.
    Difference
    0.1%
    Check dated 2025-11-25T11:12:46.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removed the government funding operating status notice/banner from the page. The study details and eligibility criteria remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T06:59:42.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The screenshots reflect only minor visual/layout updates and no changes to the study data, eligibility criteria, or primary outcomes.
    Difference
    0.5%
    Check dated 2025-11-03T21:07:35.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    - Updated operating status notice with funding lapse and links to official sources. - Bump version from v3.1.0 to v3.2.0.
    Difference
    4%
    Check dated 2025-10-06T05:37:07.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Results have moved from no results posted to results submitted, with a new version tag v3.1.0 replacing v3.0.2.
    Difference
    0.2%
    Check dated 2025-09-29T03:09:10.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1. The Back to Top element was removed.
    Difference
    0.2%
    Check dated 2025-09-14T21:42:26.000Z thumbnail image

Stay in the know with updates to PEMSYS: Pembrolizumab Modulation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PEMSYS: Pembrolizumab Modulation Clinical Trial page.